About Us
Jnana Therapeutics, a wholly owned subsidiary of Otsuka Pharmaceutical, is a clinical-stage biotechnology company leveraging its next-generation RAPID chemoproteomics platform to discover medicines for highly validated, challenging-to-drug targets to treat diseases with high unmet needs. Jnana is focused on developing first- and best-in-class therapies to treat a wide range of diseases, including rare diseases and immune-mediated diseases. Jnana’s lead program, JNT-517, which targets an allosteric site on the phenylalanine transporter SLC6A19, is a potential first-in-class oral approach for the treatment of PKU, a rare genetic metabolic disease. Located in Boston, Jnana brings together scientific leaders in small molecule drug discovery and development, and a highly experienced management team. For more information, please visit www.jnanatx.com and follow us on Twitter/X and LinkedIn.
At Jnana, you'll join a diverse, passionate team dedicated to advancing therapies for challenging diseases. Our collaborative, purpose-driven culture fosters innovation, urgency, and belonging—making Jnana a great place to work!
About the Opportunity
Jnana Therapeutics is seeking a molecular and cell biology specialist to help drive the expansion of our early discovery portfolio. In this role, you will be joining the multi-disciplinary Discovery Technologies team to validate small molecule binders and establish on-target cellular activity. The ideal candidate will have a proven track record of developing novel cell-based assays and engineering cell lines.
This is an exciting opportunity for a scientifically curious and driven scientist who embraces both challenges and opportunities with enthusiasm, contributing beyond your core responsibilities to help bring innovative medicines to patients.
Responsibilities
Preferred Qualifications & Past Experience